Trials / Completed
CompletedNCT05939713
Cera™ VSD Occluder Post Market Clinical Follow-up
A Multi-center, Single Arm, Real-World Registry Assessing the Clinical Use of the Cera™ VSD Occluder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 152 (actual)
- Sponsor
- Cardiac Children's Foundation Taiwan · Academic / Other
- Sex
- All
- Age
- 3 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this post-market registry is to assess the safety and performance of the Lifetech Cera™ VSD occluder in a real-world and on-label fashion.
Detailed description
The study intends to collect data from patients who have implanted with the device before 2022. The study is expected to completed by the end of 2024.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cera™ VSD occluder implantation | To collect data from patients who have implanted with the device before 2022. |
Timeline
- Start date
- 2023-10-13
- Primary completion
- 2025-03-04
- Completion
- 2025-03-04
- First posted
- 2023-07-11
- Last updated
- 2025-06-12
Locations
8 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05939713. Inclusion in this directory is not an endorsement.